These findings indicate that post-radiogenic activation of MAPK signalling most likely contributes to cellular radioprotective mechanism and can be radiosensitised by MEK inhibition in HNSCC cells. The gene discussed is MAP2K7; the disease is head and neck squamous cell carcinoma.